Nanophoria
4 known investors
Find your way into Nanophoria
351 people in our graph share verified history with the Nanophoria team — schools, employers, funds. One of them is your warm intro.
Giuseppe Donvitounlockedknows Claudio De Luca · together at SDA Bocconi (overlapped)
×3knows the team · via SDA Bocconi
knows the team · via University of California, San Diego
×3knows the team · via Liceo Scientifico
×2knows the team · via Università degli Studi di Padova
×2knows the team · via The Scripps Research Institute
NanoPhoria is a life sciences company that raised an €83.5 million Series A round. The page focuses on its investors and does not detail its specific product or technology.
Founders & leadership
DC
Daniele CatalucciinDaniele Catalucci leads translational cardiovascular research at NanoPhoria, focusing on cardiac disease mechanisms through approaches including RNA regulation, peptide therapies, and nanotechnology-enabled platforms. His work integrates molecular biology, biochemistry, and functional assays to develop treatments for heart failure.
MI
Michele Iafisco
AA
Alessio Alogna
CD
Claudio De LucainClaudio De Luca is a life sciences executive with 25 years of experience in MedTech and BioTech, including roles across product development, clinical validation, regulatory approval, and commercialization of biomedical products.
Investors · 4
In the news
Frequently asked questions
- What does Nanophoria do?
- NanoPhoria is a life sciences company that raised an €83.5 million Series A round. The page focuses on its investors and does not detail its specific product or technology.
- Who founded Nanophoria?
- Nanophoria was founded by Daniele Catalucci, Michele Iafisco.
- Who are Nanophoria's investors?
- Nanophoria's investors include Sofinnova Partners, XGEN Venture, CDP Venture Capital, European Innovation Council Fund.